We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dow (DOW) Subsidiary Grants Plextein License to EPL BAS
Read MoreHide Full Article
The Dow Chemical Company’s (DOW - Free Report) fully owned unit – Dow AgroSciences – and EPL Bio Analytical Services, or EPL BAS, declared a license agreement granting the latter access to patented intellectual property targeting improvements in the speed, quality and efficiency of protein quantitation in plants by mass spectrometry.
This non-exclusive license allows EPL BAS to use Dow AgroSciences’ patented intellectual property including Plextein – a high throughput method – for detecting and quantifying multiple proteins in plants. The licensing agreement will enable the expansion of this precise, efficient and cost-effective technology.
Plextein was invented by Dow AgroSciences to quickly identify and quantify proteins in plant samples. This technology uses liquid chromatography with tandem mass spectrometry (LC-MS/MS) to simultaneously measure plant-derived proteins of interest to companies and government regulators. The Plextein technology enables quantitative protein assays to be developed and validated in weeks, instead of months. The technology quantifies multiple plant proteins in a single assay, thus enabling the company to provide high-quality analytical data to the agricultural biotech industry much faster than that provided by the previous technology platform.
Dow’s shares closed around 0.1% higher at $53.49 on Aug 4.
Dow topped earnings expectations in second-quarter 2016 aided by cost-cutting and productivity actions. The U.S. chemical giant registered adjusted earnings (barring one-time items) of 95 cents per share for the quarter that outpaced the Zacks Consensus Estimate of 85 cents.
On a reported basis, the company logged profit of roughly $3.1 billion or $2.61 per share, an almost three-fold surge from a profit of around $1.1 billion or 97 cents per share recorded a year ago. The bottom line was boosted by a sizable gain associated with the Dow Corning ownership restructuring.
Dow currently has a Zacks Rank #3 (Hold).
Better-ranked stocks in the diversified chemicals space include Axiall Corp. , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , each sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Dow (DOW) Subsidiary Grants Plextein License to EPL BAS
The Dow Chemical Company’s (DOW - Free Report) fully owned unit – Dow AgroSciences – and EPL Bio Analytical Services, or EPL BAS, declared a license agreement granting the latter access to patented intellectual property targeting improvements in the speed, quality and efficiency of protein quantitation in plants by mass spectrometry.
This non-exclusive license allows EPL BAS to use Dow AgroSciences’ patented intellectual property including Plextein – a high throughput method – for detecting and quantifying multiple proteins in plants. The licensing agreement will enable the expansion of this precise, efficient and cost-effective technology.
Plextein was invented by Dow AgroSciences to quickly identify and quantify proteins in plant samples. This technology uses liquid chromatography with tandem mass spectrometry (LC-MS/MS) to simultaneously measure plant-derived proteins of interest to companies and government regulators. The Plextein technology enables quantitative protein assays to be developed and validated in weeks, instead of months. The technology quantifies multiple plant proteins in a single assay, thus enabling the company to provide high-quality analytical data to the agricultural biotech industry much faster than that provided by the previous technology platform.
DOW CHEMICAL Price
DOW CHEMICAL Price | DOW CHEMICAL Quote
Dow’s shares closed around 0.1% higher at $53.49 on Aug 4.
Dow topped earnings expectations in second-quarter 2016 aided by cost-cutting and productivity actions. The U.S. chemical giant registered adjusted earnings (barring one-time items) of 95 cents per share for the quarter that outpaced the Zacks Consensus Estimate of 85 cents.
On a reported basis, the company logged profit of roughly $3.1 billion or $2.61 per share, an almost three-fold surge from a profit of around $1.1 billion or 97 cents per share recorded a year ago. The bottom line was boosted by a sizable gain associated with the Dow Corning ownership restructuring.
Dow currently has a Zacks Rank #3 (Hold).
Better-ranked stocks in the diversified chemicals space include Axiall Corp. , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , each sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>